# Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients

> **NCT02622646** · — · UNKNOWN · sponsor: **Hospital Universitario La Fe** · enrollment: 25 (estimated)

## Conditions studied

- Hemophilia A
- Factor VIII

## Interventions

- **DRUG:** Recombinant VIII factor

## Key facts

- **NCT ID:** NCT02622646
- **Lead sponsor:** Hospital Universitario La Fe
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2016-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02622646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02622646, "Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02622646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*